영업이익률
2005년부터
계산
Abiomed Inc., 영업이익률, 장기 추세계산
| 영업이익률 | = | 100 | × | 영업이익(손실)1 | ÷ | 수익1 | |
|---|---|---|---|---|---|---|---|
| 2022. 3. 31. | 13.64% | = | 100 | × | 140,720) | ÷ | 1,031,753) |
| 2021. 3. 31. | 27.09% | = | 100 | × | 229,557) | ÷ | 847,522) |
| 2020. 3. 31. | 29.64% | = | 100 | × | 249,219) | ÷ | 840,883) |
| 2019. 3. 31. | 29.22% | = | 100 | × | 224,812) | ÷ | 769,432) |
| 2018. 3. 31. | 26.47% | = | 100 | × | 157,137) | ÷ | 593,749) |
| 2017. 3. 31. | 20.24% | = | 100 | × | 90,138) | ÷ | 445,304) |
| 2016. 3. 31. | 19.76% | = | 100 | × | 65,104) | ÷ | 329,543) |
| 2015. 3. 31. | 12.45% | = | 100 | × | 28,666) | ÷ | 230,311) |
| 2014. 3. 31. | 4.55% | = | 100 | × | 8,363) | ÷ | 183,643) |
| 2013. 3. 31. | 10.46% | = | 100 | × | 16,543) | ÷ | 158,124) |
| 2012. 3. 31. | 1.20% | = | 100 | × | 1,520) | ÷ | 126,375) |
| 2011. 3. 31. | -11.06% | = | 100 | × | (11,185) | ÷ | 101,151) |
| 2010. 3. 31. | -29.26% | = | 100 | × | (25,076) | ÷ | 85,713) |
| 2009. 3. 31. | -40.32% | = | 100 | × | (29,518) | ÷ | 73,210) |
| 2008. 3. 31. | -61.90% | = | 100 | × | (36,487) | ÷ | 58,941) |
| 2007. 3. 31. | -56.29% | = | 100 | × | (28,511) | ÷ | 50,649) |
| 2006. 3. 31. | -69.36% | = | 100 | × | (30,291) | ÷ | 43,670) |
| 2005. 3. 31. | -8.51% | = | 100 | × | (3,253) | ÷ | 38,216) |
보고서 기준: 10-K (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-03-31), 10-K (보고 날짜: 2019-03-31), 10-K (보고 날짜: 2018-03-31), 10-K (보고 날짜: 2017-03-31), 10-K (보고 날짜: 2016-03-31), 10-K (보고 날짜: 2015-03-31), 10-K (보고 날짜: 2014-03-31), 10-K (보고 날짜: 2013-03-31), 10-K (보고 날짜: 2012-03-31), 10-K (보고 날짜: 2011-03-31), 10-K (보고 날짜: 2010-03-31), 10-K (보고 날짜: 2009-03-31), 10-K (보고 날짜: 2008-03-31), 10-K (보고 날짜: 2007-03-31), 10-K (보고 날짜: 2006-03-31), 10-K (보고 날짜: 2005-03-31).
1 US$ 단위 천
경쟁사와의 비교
Abiomed Inc., 영업이익률, 장기 추세, 경쟁사와의 비교
| Abiomed Inc. | Abbott Laboratories | Cigna Group | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| 2022. 3. 31. | 13.64% | 19.16% | 4.69% | 2.41% | 25.35% | 18.15% | 8.83% |
| 2021. 3. 31. | 27.09% | 19.56% | 4.60% | 4.54% | 31.89% | 14.89% | 8.40% |
| 2020. 3. 31. | 29.64% | 15.48% | 5.12% | 5.19% | 24.09% | 16.57% | 8.76% |
| 2019. 3. 31. | 29.22% | 14.21% | 5.31% | 4.69% | 30.69% | 20.51% | 8.19% |
| 2018. 3. 31. | 26.47% | 11.94% | 8.82% | 2.07% | 32.21% | 22.20% | 7.71% |
| 2017. 3. 31. | 20.24% | 6.30% | 9.71% | 5.15% | 33.71% | 17.94% | 7.60% |
| 2016. 3. 31. | 19.76% | 15.27% | 0.00% | 5.84% | 34.95% | 18.35% | 7.03% |
| 2015. 3. 31. | 12.45% | 14.05% | 0.00% | 6.18% | 31.04% | 18.59% | 7.05% |
| 2014. 3. 31. | 4.55% | 12.84% | 0.00% | 6.31% | 25.56% | 22.42% | 7.92% |
| 2013. 3. 31. | 10.46% | 12.03% | 0.00% | 6.34% | 37.64% | 26.53% | 7.90% |
| 2012. 3. 31. | 1.20% | 20.28% | 0.00% | 5.87% | 40.30% | 0.00% | 8.42% |
| 2011. 3. 31. | -11.06% | 14.81% | 0.00% | 5.91% | 39.54% | 0.00% | 8.36% |
| 2010. 3. 31. | -29.26% | 17.31% | 0.00% | 6.39% | 39.29% | 0.00% | 8.41% |
| 2009. 3. 31. | -40.32% | 20.27% | 0.00% | 6.52% | 35.87% | 0.00% | 7.35% |
| 2008. 3. 31. | -61.90% | 19.28% | 0.00% | 6.91% | 35.53% | 0.00% | 6.54% |
| 2007. 3. 31. | -56.29% | 17.67% | 0.00% | 6.28% | 34.41% | 0.00% | 10.57% |
| 2006. 3. 31. | -69.36% | 9.09% | 0.00% | 5.57% | 28.81% | 0.00% | 9.88% |
| 2005. 3. 31. | -8.51% | 19.53% | 0.00% | 5.46% | 30.25% | 0.00% | 11.98% |
보고서 기준: 10-K (보고 날짜: 2022-03-31), 10-K (보고 날짜: 2021-03-31), 10-K (보고 날짜: 2020-03-31), 10-K (보고 날짜: 2019-03-31), 10-K (보고 날짜: 2018-03-31), 10-K (보고 날짜: 2017-03-31), 10-K (보고 날짜: 2016-03-31), 10-K (보고 날짜: 2015-03-31), 10-K (보고 날짜: 2014-03-31), 10-K (보고 날짜: 2013-03-31), 10-K (보고 날짜: 2012-03-31), 10-K (보고 날짜: 2011-03-31), 10-K (보고 날짜: 2010-03-31), 10-K (보고 날짜: 2009-03-31), 10-K (보고 날짜: 2008-03-31), 10-K (보고 날짜: 2007-03-31), 10-K (보고 날짜: 2006-03-31), 10-K (보고 날짜: 2005-03-31).